PharmaSGP Holding SE reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EUR 20.57 million compared to EUR 12.35 million a year ago. Net income was EUR 1.68 million compared to EUR 1.18 million a year ago. Basic earnings per share from continuing operations was EUR 0.14 compared to EUR 0.1 a year ago.